📰 Archives & Recherche

🇦🇺 Australie • Santé

🔍 Rechercher dans les archives

📊 2,250 articles archivé(s)
Page 113 / 113

Is it just a case of the January blues or time to quit? - The Canberra Times

Is it just a case of the January blues or time to quit? The Canberra TimesThree ways to beat "Blue Monday" BBCHow to beat the ‘winter blues’ Swind...

Reflecting on 2025

Reflecting on 2025

As we close the year, I want to thank you for helping increase ac.care's impact. Your support drives positive change [...]The post Reflecting on 2025 ...

Is it just a case of the January blues or time to quit?

Is it just a case of the January blues or time to quit?

No one relishes flicking on the laptop on the first day back after the Christmas break but when are January blues really a sign of greater dissatisfac...

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study | AAP

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study | AAP

...

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

He has a high-octane lifestyle and a solid life mantra....

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

He has a high-octane lifestyle and a solid life mantra....

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

He has a high-octane lifestyle and a solid life mantra....

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

Despite many broken bones, Daniel views himself as lucky: 'Doing what I love'

He has a high-octane lifestyle and a solid life mantra....

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

First U.S. Patient Dosed in BiPASS: Phase 3 Prostate Cancer Diagnosis Study

MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announc...

UCL Breakthrough Spurs New NHS Prostate Cancer Treatment - Mirage News

UCL Breakthrough Spurs New NHS Prostate Cancer Treatment Mirage NewsLife-extending prostate cancer drug to be offered to thousands in England BBCNHS e...